Sfoglia per Autore  CALABRO', Luana

Opzioni
Mostrati risultati da 1 a 20 di 99
Titolo Data di pubblicazione Autore(i) File
Increased concentration of circulating acid glycosaminoglycans in chronic lymphocytic leukemia and essential thrombocytaemia 1998 Calabro', L; Musolino, C; Spatari, G; Vinci, R; Calatroni, A
L'ipersplenismo: Attualità e prospettive [Hypersplenism: Current status and perspectives] 1999 Musolino, C; Alonci, A; Quartarone, C; Bellomo, G; Neri, S; Rizzo, V; Calabro', L; Pernice, F; Fr...isina, N
Markers of endothelial and platelet status in patients with essential thrombocytemia and polycythemia vera 2000 Musolino, C; Calabro', L; Alonci, A; Bellomo, G; Tringali, O; Spatari, G; Quartarone, C; Rizzo, V...; Bagnato, G; Frisina, N
Methimazole-induced agranulocytosis and quick recovery with G-CSF: case report 2001 Calabro', L; Alonci, A; Bellomo, G; D’Angelo, A; Di Giacomo, V; Musolino, C
Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignancies 2001 Maio, M; Altomonte, M; Calabro', L; Fonsatti, E
Recombinant transmembrane CD59 (CD59-TM) confers complement resistence to GPI-anchored protein detective melanoma cells. 2002 De Nardo, C; Fonsatti, E; Sigalotti, L; Calabro', L; Colizzi, F; Cortini, E; Coral, S; Altomonte,... M; Maio, M file con accesso da definire
Profilo lipidico nelle neoplasie ematologiche [Lipid profile in haematological malignancies] 2002 Musolino, C; Calabro', L; Bellomo, G; Cincotta, M; Di Giacomo, V; Pezzano, C; Lotta, B; Rizzo, V;... Guglielmo, S; Alonci, A
Soluble angiogenic factors: implications for chronic myeloproliferative disorders 2002 Musolino, C; Calabro', L; Bellomo, G; Martello, F; Loteta, B; Rizzo, V; Alonci, A
Differential levels of solubile Endoglin (CD105) in myeloid malignancies 2003 Calabro', L; Fonsatti, E; Bellomo, G; Alonci, A; Colizzi, F; Altomonte, M; Sigalotti, L; Musolino..., C; and Maio, M
Targeting of HLA-DR molecules transduces agonistic functional signals in Cutaneous melanoma 2004 Altomonte, M; Visintin, A; Tecce, R; Leopardi, A; Calabro', L; Fonsatti, E; Pucillo, C; Maio, M.
Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain 2004 Riccioni, R; Rossini, A; Calabro', L; Diverio, D; Pasquini, L; Lo Coco, F; Peschle, C; Testa, U
Levels of solubile angiogenin in chronic myeloid malignancies: clinical implications 2004 Musolino, C; Alonci, A; Bellomo, G; Loteta, B; Quartarone, E; Massara, E; Calabro', L
Epigenetic immunomodulation of hematopoietic malignancies 2005 Gattei, V; Fonsatti, E; Sigalotti, L; Degan, M; Di Giacomo, Am; Altomonte, M; Calabro', L; Maio, M.
Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implication 2005 Calabro', L; Fonsatti, E; Altomonte, M; Pezzani, L; Colizzi, F; Nanni, P; Gattei, V; Sigalotti, L...; Maio, M
Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line 2006 Coppola, S; Narciso, L; Feccia, T; Bonci, D; Calabro', L; Morsilli, O; Gabbianelli, M; De Maria, ...R; Testa, U; Peschle, C
Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin 2006 Campo, S; Campo, Gm; Avenoso, A; D’Ascola, A; Musolino, C; Calabro', L; Bellomo, G; Quararone, E;... Calatroni, A
Circulating haemopoietic and endothelial cells are decreased in COPD 2006 Palange, P; Testa, U; Huertas, A; Calabro', L; Antonucci, R; Pelosi, E; Pasquini, L; Satta, A; Mo...nici, G; Vignola, Ma; Monsignore, Mr
Differential levels of solubile angiopoietin-2 and Tie-2 in patients with haematological malignancies 2006 Quartarone, E; Alonci, A; Allegra, A; Bellomo, G; Calabro', L; D’Angelo, A; Del Fabro, V; Grasso,... A; Incotta, M; Musolino, C
Primary hepatic epithelioid hemangioendothelioma progressively responsive to Interferon-alpha: is there room for novel anti-angiogenetic treatments? 2007 Calabro', L; Di Giacomo, Am; Altomonte, M; Fonsatti, E; Mazzei, Ma; Volterrani, L; Miracco, C; Ma...io, M
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications 2007 Sigalotti, L; Fratta, E; Coral, S; Cortini, E; Covre, A; Nicolay, H; Anzalone, L; Pezzani, L; Di ...Giacomo, Am; Fonsatti, E; Colizzi, F; Altomonte, M; Calabro', L; Maio, M
Mostrati risultati da 1 a 20 di 99
Legenda icone

  •  file ad accesso aperto
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile